BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3051273)

  • 1. [Blood serum glycosaminoglycans in assessing the degree of activity in systemic lupus erythematosus].
    Piriev BA; Ivanova MM; Kaĭnova AS; Astakhova TA
    Revmatologiia (Mosk); 1988; (2):29-34. PubMed ID: 3051273
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma glycosaminoglycans in systemic lupus erythematosus.
    Friman C; Nordström D; Eronen I
    J Rheumatol; 1987 Dec; 14(6):1132-4. PubMed ID: 3437420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Certain problems of skin regeneration in patients with lupus erythematosus].
    Glavinskaia TA; Nikulin NK
    Vestn Dermatol Venerol; 1974; 48(3):3-6. PubMed ID: 4275404
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical study of Thai patients with systemic lupus erythematosus.
    Deesomchok U; Tumrasvin T
    J Med Assoc Thai; 1983 Nov; 66(11):680-7. PubMed ID: 6672150
    [No Abstract]   [Full Text] [Related]  

  • 5. [The binding capacity of serum immunoglobulins with amino acids in systemic lupus erythematosus].
    Zamulko AA; Fedorich VN; Amosova EN
    Vrach Delo; 1991 Jul; (7):47-9. PubMed ID: 1771834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical course of systemic lupus erythematosus in the male].
    Folomeev MIu; Marochitskiĭ SN; Alekberova ZS
    Ter Arkh; 1981; 53(7):30-3. PubMed ID: 7292314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-anatomical correlation in systemic lupus erythematosus].
    Losada M; Awad T; Donoso S
    Rev Med Chil; 1970; 98(9):586-94. PubMed ID: 5509796
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and clinical significance of serum antibody to ribosomal P protein in patients with systemic lupus erythematosus].
    Wu ZB; Zhu P; Wang YH; Leng N; Fan CM; Zhang HQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):120-2. PubMed ID: 15629100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of urine glycosaminoglycan determination for the characterization of pathological processes in systemic lupus erythematosus].
    Astakhova TA; Folomeeva OM
    Ter Arkh; 1981; 53(7):36-43. PubMed ID: 7292315
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiogenic activity in sera of patients with systemic lupus erythematosus.
    Sakly N; Mirshahi P; Ducros E; Soria J; Ghedira I; Mirshahi M
    Lupus; 2009 Jul; 18(8):705-12. PubMed ID: 19502266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of the lupus band test in light-protected normal skin of patients with systemic lupus erythematosus].
    Liu T; Liu FR
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):9-12. PubMed ID: 3109708
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematologic disorders in systemic lupus erythematosus patients].
    Balaban SIa; Saksonova SI; Sharko EV
    Ter Arkh; 1984; 56(5):118-9. PubMed ID: 6463880
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sialic acid, serum glycoproteins and uromucoproteins in lupus erythematosus].
    Kononova AN
    Vestn Dermatol Venerol; 1971; 45(3):18-21. PubMed ID: 5122537
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
    Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
    Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Variants in the course of systemic lupus erythematosus (based on data from Tula Province Hospital)].
    Gomova TA
    Ter Arkh; 1994; 66(4):54-7. PubMed ID: 8016732
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon production by lymphocytes from patients with systemic lupus erythematosus. Basic investigations and clinical application of the test for interferon production in serum-free media].
    Obata J
    Ryumachi; 1984 Apr; 24(2):104-15. PubMed ID: 6474277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus].
    Blum C; Zillikens D; Tony HP; Hartmann AA; Burg G
    Hautarzt; 1993 May; 44(5):290-5. PubMed ID: 8320115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematological "masks" in systemic lupus erythematosus].
    Krasovskiĭ II; Shkodkin IV; Vladimirova NN
    Ter Arkh; 1997; 69(5):58-61. PubMed ID: 9235660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.